Physician profile
Andrea Hill
NPI 1174552590
$3,439.93
in general payments reported to CMS, 2019-2025
27 companies · $40.05 in 2025
The $40.05 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $587 · 2020: $151 · 2021: $265 · 2022: $559 · 2023: $1,730 · 2024: $108 · 2025: $40.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,151 · Food and Beverage: $543 · Education: $184.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,151.43 |
| Food and Beverage | $543.09 |
| Education | $183.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,151.43 | 2023 | Da Vinci Surgical System |
| Abbvie INC. | $309.08 | 2019-2022 | |
| Aspira Women'S Health INC | $288.98 | 2022-2023 | Ova1 |
| Pfizer INC. | $280.37 | 2019-2023 | |
| Astellas Pharma US INC | $219.77 | 2021-2024 | Veozah |
| Myovant Sciences INC. | $162.52 | 2021-2022 | |
| Therapeuticsmd, INC. | $159.39 | 2019-2022 | |
| Roche Diagnostics Corporation | $135.27 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $96.54 | 2020-2021 | |
| Organon LLC | $95.90 | 2021-2024 | Nexplanon |
| Amag Pharmaceuticals, INC. | $76.10 | 2019-2020 | |
| Hologic Sales and Service, LLC | $59.77 | 2022-2024 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Avanos Medical | $44.26 | 2019-2023 | On-Q* Pump and Accessories |
| Sage Therapeutics, LLC | $43.74 | 2024 | |
| Cook Medical LLC | $40.05 | 2025 | Cook Celect |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $39.25 | 2023 | Wegovy |
| Coopersurgical, INC. | $32.74 | 2022 | |
| Exeltis, USA INC. | $31.08 | 2022 | |
| Merck Sharp & Dohme LLC | $29.12 | 2019 | |
| Ethicon US, LLC | $27.70 | 2022 | |
| Convatec INC. | $22.31 | 2023 | |
| Sumitomo Pharma America, INC. | $22.06 | 2023 | Myfembree |
| Amgen INC. | $17.99 | 2019 | |
| Smith+Nephew, INC. | $14.11 | 2023 | Pico 7 |
| Shield Therapeutics INC | $13.99 | 2024 | |
| Baxter Healthcare | $13.35 | 2021 | |
| Avion Pharmaceuticals | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.